HeartSciences (HSCS) Raw Materials (2022 - 2026)
HeartSciences (HSCS) posted quarterly Raw Materials of $373886.0 for Q2 2026, up 7.74% year-on-year from $347036.0 in Q2 2025, and up 15.76% on a QoQ basis from $322996.0 in Q4 2025.
HeartSciences (HSCS) Raw Materials (2022 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Raw Materials for 5 consecutive years, with $373886.0 the latest figure, recorded in Q2 2026.
- Quarterly Raw Materials rose 7.74% year-over-year to $373886.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $373886.0 (up 7.74% YoY) and the FY2026 annual result came in at $373886.0, up 7.74% from the prior year.
- Raw Materials improved to $373886.0 in Q2 2026 per HSCS's latest filing, from $322996.0 in the prior quarter.
- Over the last five years, Raw Materials for HSCS reached as high as $373886.0 in Q2 2026 and fell as low as $322996.0 in Q2 2023.
- A 5-year average of $336921.4 and a median of $322996.0 in 2023 frame the typical range for Raw Materials.
- Annual changes were most pronounced in 2023 — Raw Materials decreased 10.27% — and 2026, when it increased 7.74%.
- Year by year, Raw Materials stood at $359965.0 in 2022, then retreated by 10.27% to $322996.0 in 2023, then changed by 0.0% to $322996.0 in 2024, then changed by 0.0% to $322996.0 in 2025, then increased by 15.76% to $373886.0 in 2026.
- According to Business Quant data, Raw Materials over the past three periods registered $373886.0, $322996.0, and $322996.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 373,886.00 |
| Oct 31, 2025 | 322,996.00 |
| Jul 31, 2025 | 322,996.00 |
| Apr 30, 2025 | 347,036.00 |
| Jan 31, 2025 | 322,996.00 |
| Oct 31, 2024 | 322,996.00 |
| Jul 31, 2024 | 322,996.00 |
| Apr 30, 2024 | 322,996.00 |
| Jan 31, 2024 | 322,996.00 |
| Oct 31, 2023 | 322,996.00 |
| Jul 31, 2023 | 322,996.00 |
| Apr 30, 2023 | 322,996.00 |
| Jan 31, 2023 | 359,965.00 |
| Oct 31, 2022 | 359,965.00 |
| Jul 31, 2022 | 359,965.00 |
| Apr 30, 2022 | 359,965.00 |